Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
Clinical trial NCT05714085 · RECRUITING
Trial details
- NCT number
- NCT05714085
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-31
- Primary completion
- 2032-04-15
- Enrollment
- 342
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.